Cover Image

Reconsider the Indication of Implantable Cardioverter Defibrillator in Patients With Cardiac Amyloidosis

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Naoya Kataoka, Teruhiko Imamura
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Journal of Cardiovascular Electrophysiology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

In Response to: Reconsider the Indication of Implantable Cardioverter Defibrillator in Patients With Cardiac Amyloidosis
by: Ojasav Sehrawat, et al.
Published: (2024)

Optimal Indication of Superior Vena Cava Isolation in Patients With Recurrent Atrial Fibrillation
by: Reo Sasajima, et al.
Published: (2025)

Unique Feature of Catheter Ablation for Tachyarrhythmia in Pediatric Patients
by: Naoya Kataoka, et al.
Published: (2024)

Therapeutic Strategy for Patients With Heart Failure and Atrial Fibrillation
by: Naoya Kataoka, et al.
Published: (2025)

How to Demonstrate the Clinical Impact of Off‐Label Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation
by: Naoya Kataoka, et al.
Published: (2025)

Detailed mechanism of pulmonary vein reconnection after pulmonary vein isolation for atrial fibrillation
by: Naoya Kataoka, et al.
Published: (2024)

Detailed mechanism of difficulty in cryoablation for atrial fibrillation in patients with very severe obesity
by: Naoya Kataoka, et al.
Published: (2024)

Clinical implication to classify left atrial morphology to predict recurrent atrial fibrillation after catheter ablation
by: Naoya Kataoka, et al.
Published: (2024)

How to assess the implication of electrophysiological training in the contemporary era
by: Naoya Kataoka, et al.
Published: (2024)

Optimal procedural selection for atrial fibrillation catheter ablation to minimize myocardial injury and inflammatory reaction
by: Naoya Kataoka, et al.
Published: (2024)

Clinical indication of intramural needle ablation for scar‐related ventricular tachycardia in the contemporary era
by: Naoya Kataoka, et al.
Published: (2024)

Optimal therapeutic strategy for patients with atrial fibrillation and cardiac amyloidosis
by: Naoya Kataoka, et al.
Published: (2024)

Successful Strategy to Perform Pulmonary Vein Isolation and Left Atrial Appendage Closure Concomitantly
by: Naoya Kataoka, et al.
Published: (2025)

How to Improve Safety and Efficacy of Micra Leadless Pacemakers
by: Naoya Kataoka, et al.
Published: (2025)

How to Demonstrate the Underlying Mechanism of Sex Difference in the Incidence of Durable Pulmonary Vein Isolation
by: Naoya Kataoka, et al.
Published: (2025)

Expanding the Biophysical Insights Into Esophageal Heating During Radiofrequency Ablation
by: Naoya Kataoka, et al.
Published: (2025)

How to Prevent Silent Cerebral Embolism During Left Ventricular Ablation
by: Naoya Kataoka, et al.
Published: (2025)

How to Manage Ventricular Arrhythmia Following Durable Left Ventricular Assist Device Implantation
by: Naoya Kataoka, et al.
Published: (2025)

Ventricular Pacing Morphology and Its Implications for S‐ICD Eligibility
by: Naoya Kataoka, et al.
Published: (2026)

Outcomes in Patients With Mitral Annular Disjunction and an Implantable‐Cardioverter Defibrillator
by: Fatima M. Ezzeddine, et al.
Published: (2025)

Tricuspid Regurgitation as a Marker or Therapeutic Target of Atrial Fibrillation Recurrence Following Pulmonary Vein Isolation
by: Bunnshichi Miichi, et al.
Published: (2025)

Echocardiographic Predictors of Ventricular Arrhythmias in Patients With Left Ventricular Assist Devices and Implantable Cardioverter‐Defibrillator
by: Elena Efimova, et al.
Published: (2024)

Concerns Regarding “Echocardiographic Predictors of Ventricular Arrhythmias in Patients With Left Ventricular Assist Devices and Implantable Cardioverter‐Defibrillator”
by: Muhammad Nouman Javed, et al.
Published: (2025)

Safety and Clinical Outcome of Subcutaneous Implantable Cardioverter‐Defibrillators in an Asian Population: A Prospective Study
by: Karen Ka Ying Li, et al.
Published: (2025)

Inadvertent Placement of an Extravascular Implantable Cardioverter‐Defibrillator Lead in the Pericardial Space: Recognition and Successful Management at the Time of Implantation
by: Roberto Rordorf, et al.
Published: (2026)

Reducing Unnecessary Implantable Cardioverter‐Defibrillator Therapy With ENHANCED Programming: Long‐Term Outcomes of the ENHANCED‐ICD Study
by: Cheyenne S. L. Chiu, et al.
Published: (2025)

Personalized Implantable Defibrillators
by: Moied M. Al Sakan, et al.
Published: (2025)

Implantable Defibrillators: Which Is the Best Device for Each Patient?
by: Graham Peigh, et al.
Published: (2025)

Leveraging Implantable Cardiac Defibrillator Remote Transmissions to Predict the Occurrence of Atrial Fibrillation
by: Michael Scheid, et al.
Published: (2025)

A Rare Presentation of Sense‐B‐Noise With High‐Amplitude Signals in a Subcutaneous Implantable Cardioverter Defibrillator: Diagnostic Challenges and Management
by: Yukihiro Uehara, et al.
Published: (2025)

Patients Experiencing Unsuccessful Defibrillation From Implantable Cardiac Devices Remain at Elevated Risk Despite Procedural Management
by: Nathaniel Christian‐Miller, et al.
Published: (2026)

New‐Onset Device‐Detected Atrial Fibrillation in Patients With Atrial Floating Dipole Implantable Cardioverter‐Defibrillators: A Propensity Score‐Matched Comparison With Conventional Dual‐Chamber Systems
by: Gianfranco Mitacchione, et al.
Published: (2025)

Predictors of Right Ventricular Pacing in Patients Undergoing Implantable Defibrillator Placement
by: James P. Hummel, et al.
Published: (2025)

How to Indicate Implantable Cardioverter‐Defibrillator in Patients With Malignancy
by: Naoya Kataoka, et al.
Published: (2025)

Is It Time to Think Beyond the Generator in Subcutaneous Implantable Defibrillator Generator Replacements?
by: Majd A. El‐Harasis, et al.
Published: (2025)

Extravascular Cardioverter‐Defibrillator for Primary Prevention in an 11‐Year‐Old Boy With Phenotype of High Risk Overlapping Cardiomyopathies
by: M. Sterliński, et al.
Published: (2026)

Risk of Cardiovascular Implantable Electronic Device Infection in Patients With Cardiac Sarcoidosis
by: Chukwuka Ibecheozor, et al.
Published: (2026)

Lead Extraction and Outcomes in Frail Patients With Cardiac Implantable Electronic Device Infections in the United States
by: Vishwesh Bharadiya, et al.
Published: (2026)

Treatment Options, Regulatory Pathways and Global Patterns of Use for Cardiac Implantable Devices in Patients With Titanium Allergy
by: Rahul Devathu, et al.
Published: (2025)

Urban‐Rural Differences in the Outcomes of Patients Hospitalized for Cardiac Implantable Electronic Devices Infection in the United States
by: Siddharth Agarwal, et al.
Published: (2025)